Skip to main content
OpenTrials

Clinical trial condition

ACTH Syndrome, Ectopic

Explore clinical trials studying ACTH Syndrome, Ectopic. Study availability and eligibility vary by location and protocol.

31 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

ACTH Syndrome, Ectopic trial results

Completed

An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome

NCT00936741

Conditions
ACTH Syndrome, Ectopic, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +27 more
Locations
  • University of Alabama at Birmingham School of Medicine Birmingham, Alabama, United States
  • AMCR Institute Inc. Escondido, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • The Center for Diabetes and Endocrine Care Hollywood, Florida, United States
View all 15 locations
View Trial Details
Completed

Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome

NCT01371565

Conditions
ACTH Syndrome, Ectopic, Adrenal Gland Diseases, Adrenocortical Hyperfunction, +14 more
Locations
  • The Center for Diabetes and Endocrine Care Hollywood, Florida, United States
  • Sinai Hospital of Baltimore Baltimore, Maryland, United States
  • University of Michigan Medical Center Ann Arbor, Michigan, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
View Trial Details
Completed

A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome

NCT00569582

Conditions
ACTH Syndrome, Ectopic, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +27 more
Locations
  • University of Alabama at Birmingham School of Medicine Birmingham, Alabama, United States
  • AMCR Institute Inc. Escondido, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • The Center for Diabetes and Endocrine Care Hollywood, Florida, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

NCT03604198

Conditions
ACTH Syndrome, Ectopic, Adenocarcinoma, Adrenal Cortex Diseases, +30 more
Locations
  • Site 49 Phoenix, Arizona, United States
  • Site 35 Stanford, California, United States
  • Site 39 Torrance, California, United States
  • Site 50 Miami, Florida, United States
View all 48 locations
View Trial Details

Related conditions